Filtros : "Indexado no Cab Abstracts" "Casartelli, C." "CASARTELLI, CACILDA" "FMRP" Removidos: "Indexado no Current Contents" "GINECOLOGIA" "Gutierrez, M." "FMRP-RFA" Limpar

Filtros



Refine with date range


  • Source: Genetics and Molecular Research. Unidade: FMRP

    Subjects: POLIMORFISMO, NEOPLASIAS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      PINTO, G. R. et al. Prognostic value of TP53 Pro47Ser and Arg72Pro single nucleotide polymosphisms and the susceptibility to gliomas in individuals from Southeast Brazil. Genetics and Molecular Research, v. 7, n. 1, p. 207-216, 2008Tradução . . Disponível em: https://doi.org/10.4238/vol7-1gmr415. Acesso em: 19 nov. 2024.
    • APA

      Pinto, G. R., Yoshioka, F. K. N., Silva, R. L. L., Clara, C. A., Santos, M. J., Almeida, J. R. W., et al. (2008). Prognostic value of TP53 Pro47Ser and Arg72Pro single nucleotide polymosphisms and the susceptibility to gliomas in individuals from Southeast Brazil. Genetics and Molecular Research, 7( 1), 207-216. doi:10.4238/vol7-1gmr415
    • NLM

      Pinto GR, Yoshioka FKN, Silva RLL, Clara CA, Santos MJ, Almeida JRW, Burbano RR, Rey JA, Casartelli C. Prognostic value of TP53 Pro47Ser and Arg72Pro single nucleotide polymosphisms and the susceptibility to gliomas in individuals from Southeast Brazil [Internet]. Genetics and Molecular Research. 2008 ; 7( 1): 207-216.[citado 2024 nov. 19 ] Available from: https://doi.org/10.4238/vol7-1gmr415
    • Vancouver

      Pinto GR, Yoshioka FKN, Silva RLL, Clara CA, Santos MJ, Almeida JRW, Burbano RR, Rey JA, Casartelli C. Prognostic value of TP53 Pro47Ser and Arg72Pro single nucleotide polymosphisms and the susceptibility to gliomas in individuals from Southeast Brazil [Internet]. Genetics and Molecular Research. 2008 ; 7( 1): 207-216.[citado 2024 nov. 19 ] Available from: https://doi.org/10.4238/vol7-1gmr415

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024